Experienced in Lung Metastases

Arnaud D. Roth

Geneve, GE, CH 
Experienced in Lung Metastases
Geneve, GE, CH 
OverviewLocationsClinical Research

Overview

Arnaud Roth practices in Geneve, Switzerland. Mr. Roth is rated as an Experienced expert by MediFind in the treatment of Lung Metastases. His top areas of expertise are Colorectal Cancer, Anal Cancer, Stomach Cancer, Hepatectomy, and Colostomy.

His clinical research consists of co-authoring 95 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Lung Metastases.

Gender
Male

Locations

Geneve, GE, Switzerland
Other Locations
Bern, BE, Switzerland
Le Grand-saconnex, GE, Switzerland
Lausanne, VD, Switzerland
Basel, BS, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

INtegratioN of Trastuzumab, With or Without Pertuzumab, Into periOperatiVe chemotherApy of HER-2 posiTIve stOmach caNcer: the INNOVATION-TRIAL
INtegratioN of Trastuzumab, With or Without Pertuzumab, Into periOperatiVe chemotherApy of HER-2 posiTIve stOmach caNcer: the INNOVATION-TRIAL
Enrollment Status: Completed
Publish Date: July 31, 2025
Intervention Type: Drug, Procedure
Study Drugs: Cisplatin, 5-fluorouracil or Capecitabine, Trastuzumab, Pertuzumab
Study Phase: Phase 2
Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial
Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial
Enrollment Status: Terminated
Publish Date: May 16, 2025
Intervention Type: Drug
Study Drug: Aspirin
Study Phase: Phase 3
Screening Platform of the EORTC for Clinical Trials in Advanced Colorectal Cancer SPECTAcolor
Screening Platform of the EORTC for Clinical Trials in Advanced Colorectal Cancer SPECTAcolor
Enrollment Status: Completed
Publish Date: July 07, 2022
Intervention Type: Genetic
TraceIT® Hydrogel Spacer Injections for Vagina and Erectile Bundles Sparing in Rectal Cancer Patients Treated With Neoadjuvant Radiotherapy: a Feasibility Study
TraceIT® Hydrogel Spacer Injections for Vagina and Erectile Bundles Sparing in Rectal Cancer Patients Treated With Neoadjuvant Radiotherapy: a Feasibility Study
Enrollment Status: Terminated
Publish Date: May 15, 2020
Intervention Type: Device, Radiation, Procedure
Study Phase: Not Applicable
View 3 Less Clinical Trials

95 Total Publications

Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?
Journal: Current treatment options in oncology
Published: March 21, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Roth's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile